This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

How Does Iron Supplementation Affect Training and Performance in Female Collegiate Rowers?

This study has been completed.
Information provided by (Responsible Party):
Cornell University Identifier:
First received: June 27, 2011
Last updated: March 13, 2014
Last verified: March 2014
The specific aims of the current study were: 1) To determine the prevalence of IDNA in a sample of female rowers at the beginning of a training season; 2) To determine how IDNA affects endurance training and performance at the beginning of a training season; 3) To determine how iron supplementation affects iron status, training and performance in IDNA female collegiate rowers. The researchers hypothesized that IDNA affects endurance performance in female collegiate rowers both in and outside of the laboratory, and that iron supplementation of IDNA rowers will improve iron status, and consequently, training quality via increased energetic efficiency.

Condition Intervention
Iron Deficiency (Without Anemia) Dietary Supplement: Placebo Dietary Supplement: Ferrous sulfate

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Basic Science
Official Title: How Does Iron Deficiency Without Anemia (IDNA) Affect Endurance Training In Female Collegiate Endurance Athletes?

Resource links provided by NLM:

Further study details as provided by Cornell University:

Primary Outcome Measures:
  • Markers of iron status [ Time Frame: 6 weeks ]

Secondary Outcome Measures:
  • Physical performance outcomes [ Time Frame: 6 weeks ]

Enrollment: 40
Study Start Date: August 2008
Study Completion Date: December 2009
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Placebo
Red capsule (50 mg) lactose
Dietary Supplement: Placebo
100 mg lactose per day for 6 weeks
Experimental: Ferrous sulfate Dietary Supplement: Ferrous sulfate
100 mg per day of ferrous sulfate for 6 weeks

  Show Detailed Description


Ages Eligible for Study:   18 Years to 30 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • non-smoking
  • current member of college/university rowing team

Exclusion Criteria:

  • acute or chronic injury or illness at time of screening
  • physician-diagnosed asthma, musculoskeletal problems, or eating disorders
  • pregnant or lactating
  • use of steroids or other performance-enhancing substances
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01383798

United States, New York
Human Metabolic Research Unit, MVR Hall, Cornell University
Ithaca, New York, United States, 14853
Sponsors and Collaborators
Cornell University
Principal Investigator: Jere D. Haas, PhD Cornell University
Study Director: Diane M. DellaValle, PhD Cornell University
  More Information

Responsible Party: Cornell University Identifier: NCT01383798     History of Changes
Other Study ID Numbers: OSP 57149
Study First Received: June 27, 2011
Last Updated: March 13, 2014

Keywords provided by Cornell University:
iron deficiency, physical performance, female athletes

Additional relevant MeSH terms:
Anemia, Iron-Deficiency
Hematologic Diseases
Anemia, Hypochromic
Iron Metabolism Disorders
Metabolic Diseases processed this record on September 21, 2017